Video

Dr. Osarogiagbon on Geographic Disparities in Lung Cancer Mortality Rates in the United States

Raymond U. Osarogiagbon, MD, discusses geographic disparities in lung cancer mortality rates across the United States.

Raymond U. Osarogiagbon, MD, medical oncologist, Baptist Cancer Center, discusses geographic disparities in lung cancer mortality rates across the United States.

On average, rates of lung cancer are decreasing across the country, with a rapid decline in male cases beginning in the 1990s, and the same decreases in women approximately 1 decade later, according to Osarogiagbon. At the state level, however, significant differences in disease rates and outcomes remain. States in the southern and midwestern United States are at a higher risk of death from lung cancer, per capita, Osarogiagbon says.

The states with the highest rate of lunger cancer deaths include Kentucky, Mississippi, Arkansas, Tennessee, and West Virginia, according to Osarogiagbon. Moreover, these disparities increase even further at the county level, Osarogiagbon notes. Notably, in some counties across the country, rates of lung cancer are increasing, and others have plateaued with no decrease, Osarogiagbon concludes.

Related Videos
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Alastair Thompson, BSc, MBChB, MD, FRCS
C. Ola Landgren, MD, PhD
Sara M. Tolaney, MD, MPH
Adam M. Brufsky, MD, PhD, FACP
Justin M. Watts, MD
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine